Fujifilm Healthcare Europe has launched its next-generation ELUXEO 8000 endoscopy system in Europe. The ELUXEO 8000 features new therapeutic capabilities, enhanced workflow management and superior image quality. The advanced platform marks the first in a series of innovations under the company’s ‘WELCOME, FUTURE’ initiative.
Siemens Healthineers has introduced its latest magnetic resonance imaging (MRI) system specifically designed for radiation therapy at the European Society for Radiotherapy and Oncology (ESTRO) 2025 congress in Vienna. The new 1.5T Magnetom Flow RT Pro Edition represents a significant advancement in sustainable MRI technology for radiotherapy applications.
Ferno has introduced its most advanced powered transport solution to date at FDIC International 2025 in Indianapolis. The new system comprises the Power F2 Fastening System with Cross-Drive™ Technology and the Power X2 Ambulance Cot, designed to address the challenges faced by modern emergency medical services.
Elixir Medical’s LithiX Hertz Contact IVL system receives CE Mark approval for treating calcified coronary lesions without external energy source.
Edwards Lifesciences has obtained European regulatory approval for its SAPIEN M3 system, making it the world’s first transcatheter mitral valve replacement therapy delivered via a transfemoral approach for treating mitral regurgitation.
Womed has launched its pioneering medical device designed to prevent intrauterine adhesions (IUA) across 14 European countries through new distribution partnerships with Kebomed Europe and Saesco Medical.
Philips has announced that its Radiology Operations Command Center Console has received EU Medical Device Regulation (MDR) certification for remote scanning capability, enabling expert radiologists to remotely control scans and assist technologists in real-time across multiple locations in Europe.
Baxter International Inc. has announced the European launch of its Hemopatch Sealing Hemostat with room temperature storage capability, eliminating the need for refrigeration and enabling immediate accessibility in operating theatres.
The European Medicines Agency has qualified the first artificial intelligence-based tool designed to evaluate liver biopsies in patients with metabolic dysfunction-associated steatohepatitis (MASH). The system, called AIM-NASH, helps pathologists assess disease severity and reduce variability in histological scoring, with the aim of accelerating drug development for this increasingly common liver condition.
Beckman Coulter Life Sciences has launched a ground-breaking Next-Generation Basophil Activation Test (BAT) that could transform food allergy research by eliminating the need for potentially dangerous allergen exposure.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
